IPO Update: MAIA Biotechnology Targets $10 Million IPO (MAIA) – Seeking Alpha
gorodenkoffA Quick Take On MAIA Biotechnology MAIA Biotechnology, Inc. (MAIA) intends to raise $10 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is...
Towards stable, sustained Raman imaging of large samples at the nanoscale
Raman spectroscopy, an optical microscopy technique, is a non-destructive chemical analysis technique that provides rich molecular fingerprint information about chemical structure, phase, crystallinity, and molecular interactions. The technique relies on the interaction of light...
Nanoscale Raman Spectroscopy Extends Imaging Time Window of Microscale Samples
Scientists in Japan have invented a stable tip-enhanced Raman spectroscopy (TERS) imaging system that overcomes earlier restrictions of an imaging time window that was limited to 30 minutes. The scientists have demonstrated that the...
Loss of Y Chromosome in White Blood Cells Leads to Heart Failure in Men
Research by an international team of scientists headed by researchers at the University of Virginia (UVA) School of Medicine and Uppsala University, has found that loss of the Y chromosome in the white blood...
The Meta(nuclease)verse: Metagenomi Is Developing the Next Generation of Gene-Editing Therapies
GEN Edge spoke with Simon Harnest, Metagenomi’s CIO and SVP of Strategy, to discusses the company’s strategy to become a leading force in genome editing . . .
See More on the Edge
Continue reading...
Future choices about trade, diet and climate change will be key in securing nutrient...
Research by the University of Southampton shows future choices about trade, diet and climate change will be crucial in securing micronutrient food supplies for the UK. Scientists conclude that factors such as Brexit, a...
Opening new doors: First synthetic mechanosensitive potassium channel
Intrigued by the properties of ion channel proteins commonly observed in cells, Tokyo Tech researchers have developed the first synthetic mechanosensitive potassium channel using a newly developed aromatic fluorinated amphiphilic cyclophane. Displaying both “stimuli...
StockWatch: Humanigen Wilts after COVID-19 Antibody Fails NIH Trial
Lenzilumab missed its primary endpoint in the ACTIV-5/BET-B trial, conducted by the NIH’s National Institute of Allergy and Infectious Diseases. The study compared whether lenzilumab plus Gilead Sciences’ Veklury® (remdesivir) was more effective than...
Vir Biotechnology Announces Transition of Chief Scientific Officer – GlobeNewswire
SAN FRANCISCO, July 14, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Herbert “Skip” Virgin, M.D., Ph.D., Vir’s executive vice president, research and chief scientific officer, will step down effective...
Shockwave caused by Tonga underwater eruption may help scientists predict future tsunami
Using data from the eruption of the underwater volcano near Tonga in 2022, a research group at Nagoya University in Japan has used disturbances in the earth’s upper atmosphere to track the airwaves that...
